The Runway Is Shorter Than It Looks
There’s a specific look founders get when I ask, “What’s your runway?” It’s part shame, part bravado,
The Cocktail Party Problem: How to Survive Conferences, Science, and Other Noisy Mistakes
There you are—armed with a lukewarm flute of prosecco, trying to make small talk with a stem cell biologist
Let’s Do It: A Short Manifesto for the Overcommitted
There’s a peculiar optimism embedded in the English language: pulling yourself up by your bootstraps. The phrase is now
In Praise of Productive Delusion
In Germany, there is a saying: "Wenn du Visionen hast, geh zum Arzt.” If you have visions, see a
Simping for Capital: The Cult of the Curated Investor List
In the courtship rituals of modern fundraising, there exists a peculiar form of digital simping: the obsessive fawning over “curated
The Unaccountability Machine: When Systems Go Mad (and No One Gets Fired)
Dan Davies—veteran analyst, ex-regulator, and professional myth-buster—has written what might be the most depressingly accurate book of 2024:
Super-Responders and Extreme Value Theory (EVT): Unlocking Opportunities in Pharma and Biotech
In drug development, most narratives hinge on averages—median survival times, mean biomarker expression, or standard response rates. Yet, breakthroughs
A Post a Day Keeps the Excuses Away
In startups, we talk a lot about vision. Less about volume. But execution—unglamorous, cumulative, occasionally boring—is what actually
Unreasonable Hospitality: Why It Matters More Than Ever (And What Europe Should Learn)
There’s a certain kind of book that masquerades as a memoir but is, in fact, a manifesto. Will Guidara’
From Pipettes to Pep Talks: How Pharma’s Layoffs Fueled a Coaching Boom
In the grand cycle of corporate life, the pharmaceutical industry has mastered the art of layoffs while keeping its bottom